Investor sells stake in medical devices provider
Investment firm, H2 Equity Partners, has sold its holding in GBUK Group Ltd to A&M Capital Europe LLP (AMCE), a London-based middle-market private equity investment firm with €650m of assets under management.
GBUK is a Selby-based provider of acute care medical devices across the Enteral, Critical Care and Patient Handling sectors.
The group supports a range of healthcare professionals and patients in over 45 countries worldwide and uses its R&D and product development capability to expand and develop its range to meet clinical needs of patients.
H2 acquired a majority stake in the group in 2015 from the founder and worked alongside the GBUK management team to support the continued growth and development of the business.
Since acquisition, GBUK has evolved to become an own-product focused business with an extensive portfolio of critical products with international reach.
During H2’s ownership sales have more than quadrupled to £80m per annum and three acquisitions were completed during the last eight years.
A spokesman for H2 said: “GBUK is well positioned to continue on its exciting growth journey.
“The partnership with AMCE is expected to enable GBUK to enhance patient care further and drive the innovation required to support the evolving needs of patients and healthcare providers.
“Leveraging GBUK’s intimate understanding of patient needs, new product development expertise and global supply-chain capabilities, the company is well-positioned to continue delivering on this mission and support patients globally.”
H2 Equity Partners was supported by Piper Sandler, Squire Patton Boggs, PWC and Kearney.
